- Helps control elevated blood sugar in adults with type 2 diabetes mellitus.
- Effective when diet, exercise or single/dual anti-diabetic therapy is inadequate.
- Supports prevention of diabetes-related complications such as kidney damage, eye damage, and nerve problems when glycemic control is achieved.
Zoryl MV 1/0.3 Tablet - Strip of 10
Compositions : Glimepiride 1mg + Metformin 500mg + Voglibose 0.3mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Intas Pharmaceuticals Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
- Zoryl MV 1/0.3 Tablet is prescribed to manage type 2 diabetes mellitus in adults, especially when diet, exercise, or dual therapy is insufficient to control blood sugar.
- This medicine combines three active ingredients: Glimepiride, Metformin, and Voglibose. They work together to enhance insulin release, decrease glucose production in the liver, and reduce glucose absorption from the intestine.
- Typically recommended as an adjunct to a proper diet and regular exercise routine.
- Patients should not crush or chew the tablet but swallow it whole with water.
- A physician should direct the duration and dosage; self-medication is discouraged.
Product Details
Safety Advice
Side Effects
- Low blood sugar (hypoglycemia), especially when meals are missed or physical activity increases unexpectedly.
- Loss of appetite.
- Nausea and vomiting.
- Headache.
- Abdominal discomfort.
- Diarrhea.
- Allergic reactions (rare).
Precautions and Warnings
- Do not use if allergic to glimepiride, metformin, voglibose, or other sulfonylureas/sulphonamides.
- Contraindicated in patients with severe kidney, liver, heart, or respiratory problems, and in those with diabetic ketoacidosis.
- Avoid alcohol as it increases the risk of lactic acidosis and hypoglycemia.
- Notify your doctor of all current medications and health conditions before starting therapy.
- Not recommended during pregnancy or breastfeeding unless specified by a physician.
FAQs
No content available for this section.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 156057 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
- Zoryl MV 1/0.3 Tablet is prescribed to manage type 2 diabetes mellitus in adults, especially when diet, exercise, or dual therapy is insufficient to control blood sugar.
- This medicine combines three active ingredients: Glimepiride, Metformin, and Voglibose. They work together to enhance insulin release, decrease glucose production in the liver, and reduce glucose absorption from the intestine.
- Typically recommended as an adjunct to a proper diet and regular exercise routine.
- Patients should not crush or chew the tablet but swallow it whole with water.
- A physician should direct the duration and dosage; self-medication is discouraged.
- Helps control elevated blood sugar in adults with type 2 diabetes mellitus.
- Effective when diet, exercise or single/dual anti-diabetic therapy is inadequate.
- Supports prevention of diabetes-related complications such as kidney damage, eye damage, and nerve problems when glycemic control is achieved.
Side Effects
- Low blood sugar (hypoglycemia), especially when meals are missed or physical activity increases unexpectedly.
- Loss of appetite.
- Nausea and vomiting.
- Headache.
- Abdominal discomfort.
- Diarrhea.
- Allergic reactions (rare).
Precautions and Warnings
- Do not use if allergic to glimepiride, metformin, voglibose, or other sulfonylureas/sulphonamides.
- Contraindicated in patients with severe kidney, liver, heart, or respiratory problems, and in those with diabetic ketoacidosis.
- Avoid alcohol as it increases the risk of lactic acidosis and hypoglycemia.
- Notify your doctor of all current medications and health conditions before starting therapy.
- Not recommended during pregnancy or breastfeeding unless specified by a physician.
No content available for this section.
Directions for Use
Storage and Disposal
| SKU | 156057 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account